Patent ID: 11952334
Assignee: CENTER FOR INTELLIGENT RESEARCH IN CRYSTAL ENGINEERING, S.L.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A cocrystal of ubiquinone and a phenolic compound, wherein the phenolic compound is:
1) 4-hydroxybenzoic acid, and which is characterized by having an X-ray powder diffractogram that comprises characteristic peaks at 1.4 and 2.8±0.3 degrees 2 theta with Cu—Kα radiation, λ=1.5418 Å;
2) hydroquinone, and which is characterized by having an X-ray powder diffractogram that comprises characteristic peaks at 1.5 and 3.0±0.3 degrees 2 theta with Cu—Kα radiation, λ=1.5418 Å;
3) hydroquinone and which is in the form of a benzyl alcohol solvate, characterized by having an X-ray powder diffractogram that comprises characteristic peaks at 1.4, 2.9±0.3 degrees 2 theta with Cu—Kα radiation, λ=1.5418 Å;
4) orcinol, and which is characterized by having an X-ray powder diffractogram that comprises characteristic peaks at 1.5, 3.1±0.3 degrees 2 theta with Cu—Kα radiation, λ=1.5418 Å;
5) Orcinol, and which is in the form of a benzyl alcohol solvate, characterized by having an X-ray powder diffractogram that comprises characteristic peaks at 12.9, 13.6±0.3 degrees 2 theta with Cu—Kα radiation, λ=1.5418 Å;
6) phloroglucinol, and which is characterized by having an X-ray powder diffractogram that comprises characteristic peaks at 1.5, 3.0±0.3 degrees 2 theta with Cu—Kα radiation, λ=1.5418 Å;
7) resorcinol, and which is characterized by having an X-ray powder diffractogram that comprises characteristic peaks at 1.5, 3.0±0.3 degrees 2 theta with Cu—Kα radiation, λ=1.5418 Å; or
8) 2,4-dihydroxybenzoic acid, and which is characterized by having an X-ray powder diffractogram that comprises characteristic peaks at approximately 1.4 and 18.7±0.3 degrees 2 theta with Cu—Kα radiation, λ=1.5418 Å.